title: Two new drugs for skin and skin structure infections.
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D002986:Clinical Trials as Topic / Q000379:methods; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects; D010755:Organophosphates / Q000008:administration & dosage* / Q000493:pharmacokinetics; D010080:Oxazoles / Q000008:administration & dosage* / Q000493:pharmacokinetics; D017192:Skin Diseases, Bacterial / Q000188:drug therapy* / Q000378:metabolism; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000378:metabolism; D017334:Teicoplanin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics
chemical_list: D000900:Anti-Bacterial Agents; D010755:Organophosphates; D010080:Oxazoles; D017334:Teicoplanin; C469289:dalbavancin; C515040:tedizolid phosphate